Paper206648
Role of complement in the pathogenesis of experimental autoimmune myasthenia gravis.
Lennon VA and 4 others. J Exp Med, 1978. Cited by 231 papers, by iCite.
Cite this record
ConductScience Library. Role of complement in the pathogenesis of experimental autoimmune myasthenia gravis. Papers, record 206648. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/206648
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Autoimmune Diseases | Major topic |
| Complement System Proteins | Major topic |
| Myasthenia Gravis | Major topic |
| Animals | |
| Antibodies | |
| Complement C3 | |
| Elapid Venoms | |
| Immunization, Passive | |
| Neuromuscular Junction | |
| Rats | |
| Receptors, Nicotinic | |
| Synaptic Membranes | |
| Synaptic Transmission |
Source PubMed
References23
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 63374 | Antigen, host and adjuvant requirements for induction of hyperacute experimental autoimmune encephalomyelitis. | Eur J Immunol | 1976 | https://conductscience.org/library/papers/63374 | PubMed |
| 2 | 61167 | Immunology of the acetylcholine receptor. | Immunol Commun | 1976 | https://conductscience.org/library/papers/61167 | PubMed |
| 3 | 396104 | Complement receptors. | Contemp Top Mol Immunol | 1977 | https://conductscience.org/library/papers/396104 | PubMed |
| 4 | 268657 | Modulation of acetylcholine receptor by antibody against the receptor. | Proc Natl Acad Sci U S A | 1977 | https://conductscience.org/library/papers/268657 | PubMed |
| 5 | 557772 | Ultrastructural localization of the acetylcholine receptor in myasthenia gravis and in its experimental autoimmune model. | Neurology | 1977 | https://conductscience.org/library/papers/557772 | PubMed |
| 6 | 870771 | Immune complexes (IgG and C3) at the motor end-plate in myasthenia gravis: ultrastructural and light microscopic localization and electrophysiologic correlations. | Mayo Clin Proc | 1977 | https://conductscience.org/library/papers/870771 | PubMed |
| 7 | 865619 | Human myasthenic sera reduce acetylcholine sensitivity of human muscle cells in tissue culture. | Nature | 1977 | https://conductscience.org/library/papers/865619 | PubMed |
| 8 | 865618 | Myasthenia gravis serum reduces acetylcholine sensitivity in cultured rat myotubes. | Nature | 1977 | https://conductscience.org/library/papers/865618 | PubMed |
| 9 | 831074 | Myasthenia gravis. Study of humoral immune mechanisms by passive transfer to mice. | N Engl J Med | 1977 | https://conductscience.org/library/papers/831074 | PubMed |
| 10 | 830746 | Cytophilic antibodies in experimental autoimmune myasthenia gravis. | J Immunol | 1977 | https://conductscience.org/library/papers/830746 | PubMed |
| 11 | 4981797 | Two anticomplementary factors in cobra venom: hemolysis of guinea pig erythrocytes by one of them. | J Immunol | 1969 | https://conductscience.org/library/papers/4981797 | PubMed |
| 12 | 182897 | Pathological mechanisms in experimental autoimmune myasthenia gravis. II. Passive transfer of experimental autoimmune myasthenia gravis in rats with anti-acetylcholine recepotr antibodies. | J Exp Med | 1976 | https://conductscience.org/library/papers/182897 | PubMed |
| 13 | 182896 | Pathological mechanisms in experimental autoimmune myasthenia gravis. I. Immunogenicity of syngeneic muscle acetylcholine receptor and quantitative extraction of receptor and antibody-receptor complexes from muscles of rats with experimental automimmune myasthenia gravis. | J Exp Med | 1976 | https://conductscience.org/library/papers/182896 | PubMed |
| 14 | 803234 | Inhibition of experimental autoimmune renal tubulointerstitial disease in guinea pigs by depletion of complement with cobra venom factor. | Clin Immunol Immunopathol | 1975 | https://conductscience.org/library/papers/803234 | PubMed |
| 15 | 5287835 | The syndrome of myasthenia and polymyositis with comments on therapy. | Ann N Y Acad Sci | 1971 | https://conductscience.org/library/papers/5287835 | PubMed |
| 16 | 1085587 | Experimental autoimmune myasthenia gravis: cellular and humoral immune responses. | Ann N Y Acad Sci | 1976 | https://conductscience.org/library/papers/1085587 | PubMed |
| 17 | 1066997 | The motor end plate in myasthenia gravis and in experimental autoimmune myasthenia gravis. A quantitative ultrastructural study. | Ann N Y Acad Sci | 1976 | https://conductscience.org/library/papers/1066997 | PubMed |
| 18 | 1066989 | Experimental autoimmune myasthenia: clinical, neurophysiologic, and pharmacologic aspects. | Ann N Y Acad Sci | 1976 | https://conductscience.org/library/papers/1066989 | PubMed |
| 19 | 1066988 | Experimental autoimmune myasthenia gravis and myasthenia gravis: biochemical and immunochemical aspects. | Ann N Y Acad Sci | 1976 | https://conductscience.org/library/papers/1066988 | PubMed |
| 20 | 1257792 | Complement-dependent immunoglobulin G receptor function in lymphoid cells. | Science | 1976 | https://conductscience.org/library/papers/1257792 | PubMed |
Cited by61
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 231 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42693185 | Role of complement and complement-targeted therapeutics in neurological diseases. | Nat Rev Neurol | 2026 | https://conductscience.org/library/papers/42693185 | PubMed |
| 40896413 | Emerging role of complement system in the induction of neuroinflammation in adenylosuccinate lyase deficiency disorder. | Brain Behav Immun Health | 2025 | https://conductscience.org/library/papers/40896413 | PubMed |
| 40519165 | Friend or foe: assessing the value of animal models for facilitating clinical breakthroughs in complement research. | J Clin Invest | 2025 | https://conductscience.org/library/papers/40519165 | PubMed |
| 40410792 | Diverse cell types establish a pathogenic immune environment in peripheral neuropathy. | J Neuroinflammation | 2025 | https://conductscience.org/library/papers/40410792 | PubMed |
| 40279038 | Causal Variants in CHRNA1 and CHRNB1 Genes for Anti-acetylcholine Receptor Antibody Positive Myasthenia Gravis: Evidence from Bayesian Fine-Mapping and Genetic Association Study. | Mol Neurobiol | 2025 | https://conductscience.org/library/papers/40279038 | PubMed |
| 38789789 | Treating myasthenia gravis beyond the eye clinic. | Eye (Lond) | 2024 | https://conductscience.org/library/papers/38789789 | PubMed |
| 38133144 | Pathophysiology of Childhood-Onset Myasthenia: Abnormalities of Neuromuscular Junction and Autoimmunity and Its Background. | Pathophysiology | 2023 | https://conductscience.org/library/papers/38133144 | PubMed |
| 37869140 | Role of complement in myasthenia gravis. | Front Neurol | 2023 | https://conductscience.org/library/papers/37869140 | PubMed |
| 35553024 | Anti-complement Agents for Autoimmune Neurological Disease. | Neurotherapeutics | 2022 | https://conductscience.org/library/papers/35553024 | PubMed |
| 34233932 | Characterization of LRP4/Agrin Antibodies From a Patient With Myasthenia Gravis. | Neurology | 2021 | https://conductscience.org/library/papers/34233932 | PubMed |
| 33114553 | Precision Medicine in Neurology: The Inspirational Paradigm of Complement Therapeutics. | Pharmaceuticals (Basel) | 2020 | https://conductscience.org/library/papers/33114553 | PubMed |
| 32582144 | Complement Inhibitor Therapy for Myasthenia Gravis. | Front Immunol | 2020 | https://conductscience.org/library/papers/32582144 | PubMed |
| 31482201 | Role of complement and potential of complement inhibitors in myasthenia gravis and neuromyelitis optica spectrum disorders: a brief review. | J Neurol | 2021 | https://conductscience.org/library/papers/31482201 | PubMed |
| 31193726 | Investigational RNAi Therapeutic Targeting C5 Is Efficacious in Pre-clinical Models of Myasthenia Gravis. | Mol Ther Methods Clin Dev | 2019 | https://conductscience.org/library/papers/31193726 | PubMed |
| 30524436 | Complement-Activating Capacity of Autoantibodies Correlates With Disease Activity in Bullous Pemphigoid Patients. | Front Immunol | 2018 | https://conductscience.org/library/papers/30524436 | PubMed |
| 30010142 | New Pathways and Therapeutic Targets in Autoimmune Myasthenia Gravis. | J Neuromuscul Dis | 2018 | https://conductscience.org/library/papers/30010142 | PubMed |
| 28184292 | Rituximab therapy in pemphigus and other autoantibody-mediated diseases. | F1000Res | 2017 | https://conductscience.org/library/papers/28184292 | PubMed |
| 27019601 | Animal models of myasthenia gravis: utility and limitations. | Int J Gen Med | 2016 | https://conductscience.org/library/papers/27019601 | PubMed |
| 26632886 | The African-387 C>T TGFB1 variant is functional and associates with the ophthalmoplegic complication in juvenile myasthenia gravis. | J Hum Genet | 2016 | https://conductscience.org/library/papers/26632886 | PubMed |
| 26510558 | Current Treatment, Emerging Translational Therapies, and New Therapeutic Targets for Autoimmune Myasthenia Gravis. | Neurotherapeutics | 2016 | https://conductscience.org/library/papers/26510558 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| C3 | 718 | PubTator's text mining | https://conductscience.org/library/genes/718 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/206648
GET https://conductscience.org/api/papers/v1/206648/references?page=2